-
公开(公告)号:US5986055A
公开(公告)日:1999-11-16
申请号:US969106
申请日:1997-11-13
IPC分类号: A01K67/027 , A61K31/711 , A61K38/00 , A61K39/395 , A61K48/00 , A61P9/10 , C07K14/47 , C07K19/00 , C12N1/19 , C12N5/10 , C12N15/09 , C12N15/12 , C12P21/02 , C12Q1/02 , C12Q1/68
CPC分类号: C07K14/4738 , A01K2217/05 , A01K2217/075 , A61K38/00 , A61K48/00 , C07K2319/00
摘要: The present invention relates to complexes of the CDK2 protein with proteins identified as interacting with CDK2 by a modified yeast two hybrid assay system. The proteins identified to interact with CDK2 are cyclin H, cyclin I, ERH, and two gene products, hsReq*-1 and hsReq*-2, which are splice variants of the gene hsReq. Thus, the invention provides complexes of CDK2 and cyclin H, cyclin I, ERH, hsReq*-1, and hsReq*-2, and derivatives, fragments and analogs thereof. The invention also provides nucleic acids encoding the hsReq*-1 and hsReq*-2, and proteins and derivatives, fragments and analogs thereof. Methods of screening the complexes for efficacy in treating and/or preventing certain diseases and disorders, particularly cancer, atherosclerosis and neurodegenerative disease are also provided.
摘要翻译: 本发明涉及CDK2蛋白与通过修饰的酵母双杂交测定系统鉴定为与CDK2相互作用的蛋白质的复合物。 鉴定为与CDK2相互作用的蛋白质是细胞周期蛋白H,细胞周期蛋白I,ERH和两个基因产物hsReq * -1和hsReq * -2,它们是hsReq基因的剪接变体。 因此,本发明提供了CDK2和细胞周期蛋白H,细胞周期蛋白I,ERH,hsReq * -1和hsReq * -2及其衍生物,片段和类似物的复合物。 本发明还提供编码hsReq * -1和hsReq * -2的核酸,以及蛋白质及其衍生物,片段和类似物。 还提供了筛选复合物治疗和/或预防某些疾病和病症,特别是癌症,动脉粥样硬化和神经变性疾病的功效的方法。